From complex chemistry to patient-ready medicines: The value of integrated drug substance & drug product expertise
Complex molecules can present challenges across chemistry, bioavailability, formulation, manufacturability and analytical development. This Almac Voice explores how integrating drug substance and drug product expertise can create a more connected pathway from early development through to commercial supply. It highlights the value of bringing together RSM and intermediate supply, API development, formulation, analytical science, manufacturing and clinical supply to identify challenges earlier, reduce handover risk and support better-informed development decisions.
Read the full Almac Voice to discover how integrated drug substance and drug product expertise can help turn complex chemistry into patient-ready medicines.